As­traZeneca pulls back the cor­po­rate cur­tain to high­light re­al peo­ple and chat com­plex sci­ence

3 years ago
Pharma
Marketing

Pfiz­er and BioN­Tech file BLA for Omi­cron-tar­get­ing Covid-19 vac­cine

3 years ago
FDA+
Coronavirus

Ku­ra On­col­o­gy drops mul­ti­ple clin­i­cal pro­grams for J&J-dis­cov­ered tip­i­farnib

3 years ago
R&D

Rock­et Phar­ma re-ups rare dis­ease aware­ness with Em­pire State Build­ing light-up

3 years ago
Pharma
Marketing

Ready for re­tire­ment, Juan An­dres is wav­ing good­bye to Mod­er­na in May

3 years ago
People
Manufacturing

Olatec gets $40M to put an­ti-in­flam­ma­to­ry in late-stage tri­al; En­liv­en goes pub­lic, rais­es $165M

3 years ago
News Briefing

Full FDA hold de­rails clin­i­cal study of Ful­crum drug in a no good, very bad week for sick­le cell R&D

3 years ago
FDA+

Gala­pa­gos goes 0-for-3 on in­flam­ma­tion pro­gram as it cuts an ear­ly-stage can­di­date

3 years ago
R&D

Gene ther­a­py start­up Lo­can­abio lays off staff, nar­rows fo­cus on Duchenne

3 years ago
People
Startups

No­var­tis re­treat from NASH takes down $80M al­liance with Pli­ant Ther­a­peu­tics

3 years ago
R&D

Ob­sE­va makes cuts to lead­er­ship team, board of di­rec­tors in an­oth­er at­tempt to stay afloat

3 years ago
People

Nek­tar’s lat­est PhII flop threat­ens to un­rav­el $400M-plus deal with Eli Lil­ly

3 years ago
Deals
R&D

Art Levin trades the C-suite for pair of roles at Avid­i­ty; Ex-Mer­ck CEO Ken Fra­zier to chair an­oth­er com­pa­ny

3 years ago
Peer Review

Phar­ma tips ma­jor­i­ty ad spend­ing to dig­i­tal me­dia for first time, re­search finds

3 years ago
Pharma
Marketing

Roche and Blue­print agree to end col­lab­o­ra­tion for can­cer drug Gavre­to

3 years ago
Deals
Pharma

Ex-Phlow ex­ec, cousin ar­rest­ed in Ko­dak in­sid­er trad­ing scheme

3 years ago
Pharma
Law

Bris­tol My­ers, Boehringer and Roche top Ogilvy Health’s lat­est so­cial me­dia rank­ings

3 years ago
Pharma
Marketing

Bris­tol My­ers ex­pands foot­print in In­dia with drug de­vel­op­ment and IT cen­ter

3 years ago
R&D
Pharma

Mod­er­na pre­dicts $5B in 2023 Covid vac­cine sales, re­ports net in­come loss and cost in­creas­es

3 years ago
R&D
Pharma

De­moc­rats pe­ti­tion US patent of­fice to probe Mer­ck­'s new Keytru­da re­quests

3 years ago
Pharma
Law

CMS not ready to re­con­sid­er its block on cov­er­ing new Alzheimer's drugs

3 years ago
Pharma

Am­neal Phar­ma­ceu­ti­cals site in In­dia re­ceives 483 over clean­ing and oth­er qual­i­ty is­sues

3 years ago
Pharma
FDA+

Feb­ru­ary freeze hits biotech as com­pa­nies cut staff, thin pipelines and merge to sur­vive

3 years ago
People
Deals

Man­u­fac­tur­ing roundup: Eli Lil­ly’s Moun­jaro is mov­ing past a short­age — re­port; Mer­ck sells New Jer­sey fa­cil­i­ty ...

3 years ago
Manufacturing
First page Previous page 383384385386387388389 Next page Last page
A service from the Financial Times